行情

NVCR

NVCR

Novocure
NASDAQ

实时行情|Nasdaq Last Sale

78.90
-0.38
-0.48%
盘后: 79.09 +0.19 +0.24% 19:53 12/11 EST
开盘
79.26
昨收
79.28
最高
80.44
最低
77.30
成交量
75.30万
成交额
--
52周最高
98.70
52周最低
28.83
市值
78.07亿
市盈率(TTM)
-270.8548
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NVCR 新闻

  • Heres What Hedge Funds Think About NovoCure Limited (NVCR)
  • Insider Monkey.3天前
  • Time For GE To Go On The Attack, Here's How
  • Seeking Alpha - Article.3天前
  • SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors
  • GlobeNewswire.12/04 21:05
  • Raise Stops on NovoCure
  • TheStreet.com.12/04 14:55

更多

所属板块

医疗设备、用品及经销
+0.41%
医疗设备和用品
+0.28%

热门股票

名称
价格
涨跌幅

NVCR 简况

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.
展开

Webull提供Novocure Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。